생물정신의학 (Korean Journal of Biological Psychiatry)

  • 제17권2호
  • /
  • Pages.86-93
  • /
  • 2010
  • /
  • 1225-8709(pISSN)
  • /
  • 2005-7571(eISSN)
대한생물정신의학회 (The Korean Society of Biological Psychiatry)
권호 표지

정신분열병 환자의 우울증상과 불안증상이 Dexamethasone/Corticotropin Releasing Hormone 병합검사 결과에 미치는 영향

The Effect of Depression and Anxiety Symptoms on the Results of Combined Dexamethasone/Corticotropin Releasing Hormone Test in Patients with Schizophrenia

  • 한병진 (마음편한 정신과의원) ;
  • 이상익 (충북대학교 의과대학 정신과학교실) ;
  • 신철진 (충북대학교 의과대학 정신과학교실) ;
  • 손정우 (충북대학교 의과대학 정신과학교실)
  • Han, Byung-Jin (Comfort-mind Psychiatric Clinic) ;
  • Lee, Sang-Ick (Department of Psychiatry, Chungbuk National University School of Medicine) ;
  • Shin, Chul-Jin (Department of Psychiatry, Chungbuk National University School of Medicine) ;
  • Son, Jung-Woo (Department of Psychiatry, Chungbuk National University School of Medicine)
  • 발행 : 2010.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : The aim of this research is to determine the effects of depression and anxiety symptoms of schizophrenic psychopathology on the HPA axis. Methods : Twenty patients with schizophrenia were included and divided into the medication non-exposed group(n = 10) and the medication exposed group(n = 10). Evaluated scales were the Positive and Negative Syndrome Scale(PANSS), Scale for the Assessment of Negative Symptoms(SANS), Scale for the Assessment of Positive Symptoms(SAPS), Hamilton Depression Inventory(HAM-D) and Hamilton Anxiety Inventory (HAM-A), and then the combined Dexamethasone/Corticotropin Releasing Hormone(DEX/CRH) test was conducted to determine the basal level, the peak level and the area under the curve(AUC) of cortisol and adrenocorticotropic hormone(ACTH). Results : When the correlations between each psychopathology and cortisol level or ACTH AUC value were analyzed, HAM-D showed a negative correlation, whereas HAM-A showed a positive correlation. Also, the non-depression group(HAM-D ${\leq}$ 18) showed higher cortisol and ACTH concentrations than the depression group(HAM-D > 18), and the anxiety group(HAM-A ${\geq}$ 14) showed significantly higher concentrations than the non-anxiety group(HAM-D < 14)(p < 0.05). Also, as for the comparison between the medication non-exposed group and the medication exposed group, the non-exposed group showed significantly higher cortisol and ACTH concentration than exposed group(p < 0.05). Conclusion : This study suggest that anxiety symptoms rather than depression symptoms are related to the increased activity of the HPA axis of schizophrenics.

키워드

참고문헌

  1. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 1981;38:15-22. https://doi.org/10.1001/archpsyc.1981.01780260017001
  2. Rubin R, Dinan TG , Scott LV. The neuroendocrinology of affective disorders. In: Pfaff D, Arnold AP, Etgen AM, Fahrbach SE, Moss RL, Rubin RT, editors. Hormone, Brain and Behaviour. New York: Academic Press; 2001. p.230-245.
  3. Yeragani VK. The incidence of abnormal dexamethasone suppression test in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls. Can J Psychiatry 1990;35:128-132. https://doi.org/10.1177/070674379003500204
  4. Gil-Ad I, Dickerman Z, Amdursky S, Laron Z. Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compaired to control subjects. Psychopharmacology(Berl)1986;88:496-499.
  5. Kaneko M, Yokoyama F, Hoshino Y, Takahagi K, Murata S, Watanabe M, et al. Hypothalamic-pituitaryadrenal function in chronic schizophrenia: association with clinical features. Neuropsychobiology 1992;25:1-7. https://doi.org/10.1159/000118800
  6. Ismail K, Murray RM, Wheeler MJ, O'keane V. The dexamethasone suppression test in schizophrenia. Psychol Med 1998;28:311-317. https://doi.org/10.1017/S0033291797006521
  7. Coppen A, Abou-Salch M, Millin P, Metcalfe M, Harwood J, Bailey J. Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry 1983;142:498-504. https://doi.org/10.1192/bjp.142.5.498
  8. Tandon R, Mazzara C, DeQuardo J, Craig KA, Meador- Woodruff JH, Goldman R, et al. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biol Psychiatry 1991;29:953-964. https://doi.org/10.1016/0006-3223(91)90353-N
  9. Roy A, Pickar D, Doran A, Wolkowitz O, Gallucci W, Chrousos G, et al. The corticotropin-releasing hormone stimulation test in chronic schizophrenia. Am J Psychiatry 1986;143:1393-1397. https://doi.org/10.1176/ajp.143.11.1393
  10. Holsboer-Taschsler E, Buol C, Wiedemann K, Holsboer F. Dexamethasone suppression test in severe schizophrenic illness: effect of plasma dexamethasone and caffeine levels. Acta Psychiatry Scand 1987;75:608-613. https://doi.org/10.1111/j.1600-0447.1987.tb02844.x
  11. Baumgartner A, Graf KJ, Kurten I. Serial dexamethasone suppression test in psychiatric illness: Part I. A study in schizophrenia and mania. Psychiatry Res 1986; 18:25-43. https://doi.org/10.1016/0165-1781(86)90058-2
  12. Heuser I, Yassouridis A, Holsboer F. The dexamethasone/ CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 1994;28:341-356. https://doi.org/10.1016/0022-3956(94)90017-5
  13. Halbreich U, Zumoff B, Kream J, Fukushima DK. The mean 1300-1600h plasma cortisol concentration as a diagnostic test for hypercortisolism. J Clin Endocri-nol Metab 1982;54:1262 -1264. https://doi.org/10.1210/jcem-54-6-1262
  14. Kraus RP, Hux M, Grof P. Psychotropic drug withdrawl and the dexamethasone suppression test. Am J Psychiatry 1987;144:82-85. https://doi.org/10.1176/ajp.144.1.82
  15. Kay SR, Fiszbein A, Opler LA. Positive and negative syndrome scale(PANSS)for schizophrenia. Schizophr Bull 1987;13:261-276. https://doi.org/10.1093/schbul/13.2.261
  16. Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatr Assoc 2001;40:1090-1105.
  17. Andreasen NC, Flaum M, Swayze VW 2nd, Tyrrell G , Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry 1990;47: 615-621. https://doi.org/10.1001/archpsyc.1990.01810190015002
  18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62. https://doi.org/10.1136/jnnp.23.1.56
  19. Lammers CH, Garcia-Borreguero D, Schimider J, Gotthardt U, Dettling M, Holsboer F, et al. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II. Biol Psychiatry 1995;38:803-807. https://doi.org/10.1016/0006-3223(95)00065-8
  20. Kim KS, Sung YS, Chae JH, Bahk WM, Lee CT, Jun TY. Changes in serum cortisol levels and clinical symptoms after the administration of risperidone in schizophrenic patients. J Korean Neuropsychiatr Assoc 2003; 39:381-389.
  21. Pivac N, Muck-Seler D, Jakovljevie M. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms. Neuropsychobiology 1997;36:19-21. https://doi.org/10.1159/000119354
  22. Jakovljevic M, Muck-Seler D, Pivac N, Crncevic Z. Platelet 5-HT and plasma cortisol concentration after dexamethasone suppression test in patients with different time course of schizophrenia. Neuropsychobiology 1998;37:142-145. https://doi.org/10.1159/000026493
  23. Muck-Seler D, Pivac N, Jakovljevic M, Brzovic Z. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biol Psychiatry 1999;45:1433-1439. https://doi.org/10.1016/S0006-3223(98)00174-7
  24. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 1993;18:1-32.
  25. Kaneda Y, Fujii A, Ohmori T. The hypothalamic-pituitary- adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:935-938. https://doi.org/10.1016/S0278-5846(02)00208-7
  26. Dewan MJ, Pandurangi AK, Boucher ML, Levy BF, Major LF. Abnormal dexamethasone suppression test results in chronic schizophrenic patients. Am J Psychiatry 1982;139:1501-1503. https://doi.org/10.1176/ajp.139.11.1501
  27. Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ. Combined dexamethasone/corticotropin- releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol Psychiatry 1995;38:797-802. https://doi.org/10.1016/0006-3223(95)00064-X
  28. Sharma RP, Pandey GN, Janicak PG, Peterson J, Comaty JE, Davis JM. The effect of diagnosis and age on the DST: a metaanalytic approach. Biol Psychiatry 1988; 24:555-568. https://doi.org/10.1016/0006-3223(88)90166-7
  29. Addington D, Addington J. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia. Can J Psychiatry 1990;35:430-433. https://doi.org/10.1177/070674379003500512